Novo Nordisk Announces Job Cuts Amidst Intensified Competition
10.09.2025, 14:00
Novo Nordisk, the manufacturer of popular obesity medications Ozempic and Wegovy, has announced plans to cut approximately 9,000 jobs globally, representing around 11% of its workforce. This decision comes as the company faces increasing competition, particularly from rival Eli Lilly, affecting its...